5/23/2022  5:35:24 PM Chg. -0.800 Volume Bid5/23/2022 Ask5:35:24 PM Market Capitalization Dividend Y. P/E Ratio
41.480EUR -1.89% 44,919
Turnover: 1.87 mill.
-Bid Size: - -Ask Size: - 877.92 mill.EUR 1.18% 25.40

Business description

The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The three business segments are: Radiation Therapy, Isotope Products and Radiopharma. Eckert & Ziegler was founded in 1997 as a holding company.
 

Management board & Supervisory board

CEO
Dr. Andreas Eckert
Management board
Dr. Harald Hasselmann, Dr. Lutz Helmke
Supervisory board
Prof. Dr. Wolfgang Maennig, Albert Rupprecht, Dr. Edgar Löffler, Frank Perschmann, Jutta Ludwig, Prof. Dr. Helmut Grothe
 

Company data

Name: Eckert & Ziegler Strahlen- und Medizintechnik AG
Address: Robert-Rössle-Str. 10,D-13125 Berlin
Phone: +49-30-941084-0
Fax: +49-30-941084-112
E-mail: info@ezag.de
Internet: www.ezag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 59.16%
IPO date: -

Investor relations

Name: Karolin Riehle
IR phone: +49-30-941084-138
IR Fax: -
IR e-mail: karolin.riehle@ezag.de

Company calendar

CW 23 | 6/1/2022 General Shareholder Meeting
CW 24 | 6/6/2022 Dividend Payment
CW 33 | 8/11/2022 Interim Report 2nd Quarter/6 Months
CW 47 | 11/14/2022 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
59.16%
Eckert Wagniskapital und Frühphasenfinanzierung GmbH
 
30.76%
Invesco Ltd.
 
5.07%
J.P. Morgan Investment Management Inc.
 
2.87%
eigene Aktien
 
2.14%